ATE463572T1 - Rekombinanter faktor viii mit erhöhter spezifischer aktivität - Google Patents

Rekombinanter faktor viii mit erhöhter spezifischer aktivität

Info

Publication number
ATE463572T1
ATE463572T1 AT04812686T AT04812686T ATE463572T1 AT E463572 T1 ATE463572 T1 AT E463572T1 AT 04812686 T AT04812686 T AT 04812686T AT 04812686 T AT04812686 T AT 04812686T AT E463572 T1 ATE463572 T1 AT E463572T1
Authority
AT
Austria
Prior art keywords
factor viii
recombinant factor
specific activity
increased specific
relates
Prior art date
Application number
AT04812686T
Other languages
English (en)
Inventor
Philip Fay
Hironao Wakabayashi
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Application granted granted Critical
Publication of ATE463572T1 publication Critical patent/ATE463572T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04812686T 2003-12-03 2004-12-02 Rekombinanter faktor viii mit erhöhter spezifischer aktivität ATE463572T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52666403P 2003-12-03 2003-12-03
PCT/US2004/040234 WO2005055930A2 (en) 2003-12-03 2004-12-02 Recombinant factor viii having increased specific activity

Publications (1)

Publication Number Publication Date
ATE463572T1 true ATE463572T1 (de) 2010-04-15

Family

ID=34676640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04812686T ATE463572T1 (de) 2003-12-03 2004-12-02 Rekombinanter faktor viii mit erhöhter spezifischer aktivität

Country Status (7)

Country Link
US (1) US7855274B2 (de)
EP (1) EP1699469B1 (de)
AT (1) ATE463572T1 (de)
AU (1) AU2004296768B2 (de)
CA (1) CA2547569C (de)
DE (1) DE602004026474D1 (de)
WO (1) WO2005055930A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2633916T3 (es) 2004-11-12 2017-09-26 Bayer Healthcare Llc Modificación de FVIII dirigida al sitio
EP1915176A4 (de) 2005-07-15 2008-12-03 Univ Vermont Hochsensitive immunassays und antikörper zum nachweis von blutfaktor viii
EP2363429A1 (de) 2006-03-10 2011-09-07 Goodrich Corporation Blitzschlagschutz mit geringer Dichte zur Verwendung in Flugzeugen
MX2010004813A (es) * 2007-11-01 2010-10-04 Univ Rochester Factor viii recombinante que tiene estabilidad incrementada.
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
AU2011223710B2 (en) 2010-03-01 2016-04-14 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US8637448B2 (en) 2010-09-14 2014-01-28 University Of Rochester Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface
SI3013855T1 (sl) * 2013-06-24 2021-06-30 Xiao, Weidong Mutantne sestave faktorja VIII in metode
PE20250736A1 (es) 2016-04-15 2025-03-10 Univ Pennsylvania Terapia genica para tratar la hemofilia a
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
CN111651033B (zh) * 2019-06-26 2024-03-05 广州虎牙科技有限公司 一种人脸的驱动显示方法、装置、电子设备和存储介质

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422260A (en) * 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US6376463B1 (en) 1992-04-07 2002-04-23 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5576291A (en) 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5880327A (en) 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US20040092442A1 (en) 1996-04-24 2004-05-13 University Of Michigan Inactivation resistant factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6593291B1 (en) 1997-02-06 2003-07-15 Entremed, Inc. Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
US5994310A (en) 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
US6759216B1 (en) * 1998-11-06 2004-07-06 Emory University Glycosylated, low antigenicity low immunogenicity factor VIII
EP1038959A1 (de) 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Faktor VIII ohne B-Domän, der ein oder mehrere Insertionsstücke von verkürztem Intron I des Faktors IX enthält
EP1194161B1 (de) 1999-07-13 2005-11-23 Biovitrum Ab Zusammensetzungen mit stabilem faktor viii
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
EP1319016A4 (de) 2000-09-19 2006-05-10 Univ Emory Modifizierter faktor viii
EP1233064A1 (de) 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modifizierte Faktor VIII cDNA und deren Verwendung bei der Produktion von Faktor VIII
EP2110385A1 (de) 2001-06-14 2009-10-21 The Scripps Research Institute Stabilisierte Faktor VIII mit manipulierten Disulfid-Bindungen
EP1424344A1 (de) 2002-11-29 2004-06-02 Aventis Behring Gesellschaft mit beschränkter Haftung Modifizierte cDNA des Factors VIII und Derivate davon
US7041635B2 (en) 2003-01-28 2006-05-09 In2Gen Co., Ltd. Factor VIII polypeptide
US7211559B2 (en) * 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods

Also Published As

Publication number Publication date
EP1699469B1 (de) 2010-04-07
AU2004296768A1 (en) 2005-06-23
US20070265199A1 (en) 2007-11-15
CA2547569C (en) 2013-04-16
DE602004026474D1 (de) 2010-05-20
WO2005055930A3 (en) 2005-08-18
WO2005055930A2 (en) 2005-06-23
EP1699469A4 (de) 2007-01-24
US7855274B2 (en) 2010-12-21
CA2547569A1 (en) 2005-06-23
AU2004296768B2 (en) 2010-06-24
EP1699469A2 (de) 2006-09-13

Similar Documents

Publication Publication Date Title
EP2295555A3 (de) Polypeptide mit Lipase-Aktivität und diese kodierende Polynukleotide
NO20042570L (no) Antimikrobielle polypeptider fra Pseudoplectania nigrella
DK1266011T3 (da) Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider
WO2002095014A3 (en) Polypeptides having cellobiase activity and polynucleotides encoding same
EP2284185A3 (de) Bacillusprotein-Deaktivierung
DK1831362T3 (da) Syreaktive svampeproteaser
EP2857515A3 (de) Polypeptide mit verstärkter amylolytischer Aktivität und Polynukleotide zur Codierung davon
AU2003291962A8 (en) Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
EA201070764A1 (ru) Полипептиды, обладающие активностью, усиливающей лизис целлюлозы, и кодирующие их полинуклеотиды
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
DE602004021836D1 (de) Meg1-endospermspezifische promotoren und gene
WO2006047469A3 (en) Polypeptides having lipase activity and polynucleotides encoding same
WO2002086144A3 (en) Compositions and methods for recombinational cloning of nucleic acid molecules
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
WO2022074037A3 (en) Alpha-amylase variants
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
EA200401531A1 (ru) Новые фосфолипазы и их применение
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
ATE542913T1 (de) Promotorvarianten zur expression von genen in einer pilzzelle
EA200700233A1 (ru) Новая последовательность для повышения экспрессии нуклеиновой кислоты
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
DE60040077D1 (de) Vermehrungsproteine von pflanzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties